Variables p53 R282W mutation Chi square df p-value
  +VE (%) -VE (%)      
Number of Cases(100) 58(58%) 42(42%) 4.5 1 0.03
Gender
Males 37(61.6) 23(38.3) 0.49 1 0.48
Females 21(52.5) 19(47.5)
Age
<20 yrs 8(72.7) 3(27.2) 1.66 3 0.64
20-30 yrs 12(57.1) 9(42.8)      
30-40 yrs 16(61.5) 10(38.4)      
>40 yrs 22(52.3) 20(47.6)      
Phase
Chronic 31(35.2) 37(64.7) 13.5 2 0.001
Accelerated 14(88.2) 3(11.7)      
Blast Crisis 13(60.0) 2(40.0)      
TLC
<20,000 17(42.5) 23(57.5) 6.41 1 0.011
>20,000 42(70.0) 18(30.0)      
Platelet Count
Normal count 19(39.5) 29(60.4) 12.85 2 0.0016
Thrombocytopenia 27(75.0) 9(25.0)
Thrombocytosis 12(75.0) 4(25.0)
Spleen size
Spleenomegaly present 43(65.0) 23(34.8) 3.26 1 0.07
Spleenomegaly absent 15(44.1) 19(55.8)
Haematological Response (HR)
Major HR 7(33.3) 14(66.6) 8.1 2 0.017
Minor HR 10(52.6) 9(47.3)
Minimal  HR 41(68.3) 19(31.6)
Table 7: Association of p53 R282W mutation in CML patients with clinicopathological parameters.
Goto home»